PT

Dados B3 › FLRY3 × HAPV3

FLRY3 × HAPV3

FLRY3

FLEURY SA
Saúde

14 restated figures

HAPV3

HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A.
Saúde

40 restated figures

Indicators

Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.

indicatorFLRY3HAPV3year
ROE11.9%-0.3%2025
ROIC11.6%1.8%!2025
ROA4.5%-0.2%2025
Gross margin26.6%11.8%2025
EBIT margin14.7%4.6%2025
Net margin7.2%-0.5%2025
Net debt/EBITDA1.47x1.66x2025
Current ratio1.97x1.90x2025
Revenue growth (1y)7.9%9.2%2025
Revenue growth (5y CAGR)22.8%29.8%2025
Piotroski F-Score6/96/92025

Point-in-time multiples

Priced at the first session on or after the day each filing became public — never the period close.

indicatorFLRY3HAPV3year
P/E14.26x-27.50x2025
P/B1.75x0.08x2025
EV/EBITDA5.58x2.95x2025
FCF yield18.6%26.2%2025

FLRY3 · HAPV3 · filter the whole market · methodology

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:46 UTC. If this does not match /saude, you are reading a cached copy.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:46 UTC. If this does not match /saude, you are reading a cached copy.